| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.005 |